Next, IL-4 was significantly increased in the fibrotic and in the inflamed mucosa and deeper layers when compared with the unaffected region in non-IBD controls and patients with CD (P < 0.05 for all comparisons). This evidence concerns the gene IL4 and inflammatory bowel disease.